A Phase I Trial of Alpelisib Combined With Capecitabine in Patients With HER2-Negative Metastatic Breast Cancer. File DM, Abdou Y, Force J, Moore DT, et al. Clin Breast Cancer 2024 Aug 8:S1526-8209(24)00213.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

File DM, Abdou Y, Force J, Moore DT, et al. A Phase I Trial of Alpelisib Combined With Capecitabine in Patients With HER2-Negative Metastatic Breast Cancer. Clin Breast Cancer 2024 Aug 8:S1526-8209(24)00213.
PMID: 39217059